Upsher-Smith Laboratories, Inc., 6701 Evenstad Drive, Maple Grove, MN, 55369, USA.
Macromol Biosci. 2013 Dec;13(12):1700-10. doi: 10.1002/mabi.201300323. Epub 2013 Nov 27.
Self-healing (SH) poly(lactic-co-glycolic acid) (PLGA) microspheres are a unique class of functional biomaterials capable of microencapsulating process-sensitive proteins by simple mixing and heating the drug-free polymer in aqueous protein solution. Drug-free SH microspheres of PLGA 50/50 with percolating pore networks of varying porosity (ϵ = 0.49-73) encapsulate increasing lysozyme (≈1 to 10% w/w) with increasing ϵ, with typically ≈20 to 25% pores estimated accessible to entry by the enzyme from the external solution. Release kinetics of lysozyme under physiological conditions is continuous over more than two weeks and most strongly influenced by ϵ and protein loading before reaching a lag phase until 28 d at the study completion. Recovered enzyme after release is typically predominantly monomeric and active. Formulations containing acid-neutralizing MgCO3 at ≥ 4.3% exhibit >97% monomeric and active protein after the release with full mass balance recovery. Hence, control of SH polymer ϵ is a key parameter to development of this new class of biomaterials.
自愈合(SH)聚(乳酸-共-乙醇酸)(PLGA)微球是一类独特的功能生物材料,能够通过将无药物的聚合物简单混合并在水相蛋白溶液中加热,来微封装对处理过程敏感的蛋白质。具有不同孔隙率(ε=0.49-73)的贯通孔网络的无药物 SH PLGA 50/50 微球可以包封越来越多的溶菌酶(≈1 至 10%w/w),随着 ε 的增加而增加,通常估计有 ≈20 至 25%的孔可被酶从外部溶液进入。在生理条件下,溶菌酶的释放动力学持续超过两周,并且在达到滞后阶段之前,ε 和蛋白质负载对其影响最大,直到研究完成时的 28 天。释放后回收的酶通常主要是单体和活性的。在释放后含有≥4.3%中和酸的 MgCO3 的制剂中,具有完整质量平衡回收的>97%的单体和活性蛋白质。因此,控制 SH 聚合物 ε 是开发这种新型生物材料的关键参数。